Barclays’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$188K Buy
126,963
+102,653
+422% +$152K ﹤0.01% 3575
2025
Q1
$62K Sell
24,310
-10,013
-29% -$25.5K ﹤0.01% 3841
2024
Q4
$65K Hold
34,323
﹤0.01% 3896
2024
Q3
$35K Sell
34,323
-1,104
-3% -$1.13K ﹤0.01% 3980
2024
Q2
$41K Sell
35,427
-47,007
-57% -$54.4K ﹤0.01% 3752
2024
Q1
$105K Sell
82,434
-43,268
-34% -$55.1K ﹤0.01% 3625
2023
Q4
$224K Buy
125,702
+79,191
+170% +$141K ﹤0.01% 3456
2023
Q3
$77K Buy
46,511
+33,281
+252% +$55.1K ﹤0.01% 3419
2023
Q2
$26K Buy
13,230
+11,230
+562% +$22.1K ﹤0.01% 3919
2023
Q1
$4K Hold
2,000
﹤0.01% 4182
2022
Q4
$3K Hold
2,000
﹤0.01% 4264
2022
Q3
$2K Hold
2,000
﹤0.01% 4508
2022
Q2
$2K Hold
2,000
﹤0.01% 4577
2022
Q1
$2K Buy
+2,000
New +$2K ﹤0.01% 4670
2019
Q4
Sell
-2,003
Closed -$4K 4140
2019
Q3
$4K Buy
2,003
+3
+0.2% +$6 ﹤0.01% 3971
2019
Q2
$9K Hold
2,000
﹤0.01% 4034
2019
Q1
$9K Hold
2,000
﹤0.01% 4026
2018
Q4
$6K Hold
2,000
﹤0.01% 3685
2018
Q3
$15K Hold
2,000
﹤0.01% 3959
2018
Q2
$9K Hold
2,000
﹤0.01% 3923
2018
Q1
$11K Hold
2,000
﹤0.01% 3946
2017
Q4
$13K Hold
2,000
﹤0.01% 3793
2017
Q3
$12K Hold
2,000
﹤0.01% 3386
2017
Q2
$17K Hold
2,000
﹤0.01% 3320
2017
Q1
$27K Hold
2,000
﹤0.01% 3289
2016
Q4
$9K Sell
2,000
-49,000
-96% -$221K ﹤0.01% 3295
2016
Q3
$290K Sell
51,000
-11,959
-19% -$68K ﹤0.01% 1959
2016
Q2
$403K Sell
62,959
-6,479
-9% -$41.5K ﹤0.01% 1849
2016
Q1
$0 Sell
69,438
-1,885
-3% ﹤0.01% 3619
2015
Q4
$713K Buy
+71,323
New +$713K ﹤0.01% 1511
2015
Q1
Sell
-6
Closed 4136
2014
Q4
$0 Hold
6
﹤0.01% 4279
2014
Q3
$0 Hold
6
﹤0.01% 4420
2014
Q2
$0 Hold
6
﹤0.01% 4404
2014
Q1
$0 Hold
6
﹤0.01% 4370
2013
Q4
$0 Hold
6
﹤0.01% 4394
2013
Q3
$0 Sell
6
-14
-70% ﹤0.01% 4253
2013
Q2
$1K Buy
+20
New +$1K ﹤0.01% 4260